Dante Genomics
Dante Omics is a global genomics and precision medicine company founded in 2016 by two Italian co-founders. The company's mission is to make genomics accessible for everyone by leveraging whole genome sequencing technology and variant interpretation to inform health decisions. They offer a range of services including Whole Exome Sequencing, Whole Genome Sequencing, Transcriptomics, Proteomics, and specialized areas like Oncology and Drug Discovery. Their proprietary AVANTI software aids in multiomics data analysis and interpretation. Dante Omics has processed over 5 million COVID samples and operates in 6 countries, aiming to accelerate science for better healthcare and save lives through a more human approach.
Dante Genomics
Dante Omics is a global genomics and precision medicine company founded in 2016 by two Italian co-founders. The company's mission is to make genomics accessible for everyone by leveraging whole genome sequencing technology and variant interpretation to inform health decisions. They offer a range of services including Whole Exome Sequencing, Whole Genome Sequencing, Transcriptomics, Proteomics, and specialized areas like Oncology and Drug Discovery. Their proprietary AVANTI software aids in multiomics data analysis and interpretation. Dante Omics has processed over 5 million COVID samples and operates in 6 countries, aiming to accelerate science for better healthcare and save lives through a more human approach.